Trial Profile
Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 26 Oct 2012
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Epilepsy; Temporal-lobe-epilepsy
- Focus Pharmacodynamics
- 28 Jun 2010 Planned initiation date changed from 1 Oct 2009 to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 04 Oct 2009 New trial record